hopeless stock to hold for long term....kinda funny...for a billion ringgit biz company yearly but net profit only 20+ million per qtr....need someone from MACCC to check it out....
just a matter of time it should touch 7.00 in q3 when receivables start coming in fr the govt biz. don't wait anymore. otherwise no chance to buy at this current price i.e below 5.00
Still remembered I started to buy this counter on 24/2 at rm4.29 and dropped to about rm4.10 after 2 weeks. I still bought in for every 5cents down. Now, within half year , it was already achieved 10%. so, don't worry. Even down >10 cents is normal as the share volume for retailers is less than 20%! Important is long term trend is up and dividend is better than FD.
4 cents dividen is too small for pharma price... if u buy and sell today, u can profit 4 cents... yet after minus brokerage... I still got 2 cents .. for just 3 to 4 minutes ...hehe
Yes, this counter can be goreng due to little volume in market but the fundamental of this counter is solid and like hidden gem. With quarterly dividend + overall better than fd(at present)+ start contribution from Indonesia& Arab venture for next 3 years+ less impact by ecomonic cycle....
Name Dato' Farshila Emran Address No. 21, Jalan 5/1B, Kemensah Residency Taman Kemensah Heights 68000 Ampang, Selangor Descriptions(Class & nominal value) Ordinary shares of RM0.50 each
Details of changes
Currency: Malaysian Ringgit (MYR)
Type of transaction
Date of change
No of securities
Price Transacted (RM)
Disposed
04/09/2014
25,000
4.630
Circumstances by reason of which change has occurred Sale of shares Nature of interest Direct Consideration (if any)
Total no of securities after change
Direct (units) 434,000 Direct (%) 0.1676 Indirect/deemed interest (units) Indirect/deemed interest (%) Date of notice 04/09/2014
9M14 core net profit of RM71.9m, came in within our expectations but slightly ahead of consensus’ estimates, accounting for 77% and 83% of HLIB and consensus full year estimates, respectively. Declared 3rd single tier dividend of 8.0 sen per share (3Q13: 3.0 sen) with ex-date on 5th Dec. 3Q14 revenue gained 13.9% yoy to RM502.1m contributed by the entire core business operations. However, qoq sales contracted 4.4% due to seasonally lower demand. Logistics and Distribution Division posted more than three-fold increase in PBT qoq, boosted by higher ASP coupled with higher sales volume. Manufacturing Division’s PBT slipped due to lower off-take for in-house products from government hospitals as well as higher R&D expenses. Moving forward, Pharmaniaga remains positive as the pharmaceutical sector in Malaysia is showing improved prospects. Reiterate BUY with unchanged fair value of RM5.30 based on FY15 P/E multiple of 14.5x, 10% discount to US peers.
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
MQ Trader 894 views | 4 d ago
0:17
New IPO: An enterprise IT solutions provider that provides implementation services, maintenance, support and professional services, Vetece Holdings Bhd aims to list on the Ace Market!
MQ Trader 761 views | 8 d ago
0:17
New IPO: A manufacturing and trading of biomass fuel products, particularly PKS and wood pellets company, Elridge Energy Holdings Bhd aims to list on the Ace Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
hw0706
800 posts
Posted by hw0706 > 2014-06-12 15:22 | Report Abuse
still like a snail.